➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
McKesson
Dow
Express Scripts
McKinsey

Last Updated: August 8, 2020

DrugPatentWatch Database Preview

INTRON A Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for INTRON A

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Roswell Park Cancer InstitutePhase 1/Phase 2
Editas Medicine, Inc.Phase 1/Phase 2
AllerganPhase 1/Phase 2

See all INTRON A clinical trials

Recent Litigation for INTRON A

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Bay State Milling Company v. Arcadia Biosciences, Inc.2019-04-01
Par Pharmaceutical, Inc. v. Amphastar Pharmaceuticals, Inc.2018-12-20
Boston Heart Diagnostics Corporation v. MD Labs, Inc.2018-01-05

See all INTRON A litigation

PTAB Litigation
PetitionerDate
Regeneron Pharmaceuticals, Inc.2019-09-20
Regeneron Pharmaceuticals, Inc.2019-05-14
Baylor College of Medicine2018-04-18

See all INTRON A litigation

Pharmacology for INTRON A

Company Disclosures: US Patents for INTRON A

These patents were extracted from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Schering Corporation (Madison, NJ) 2002-11-19 RX company
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Biogen N.V. (Curacao, AN) 2002-07-23 RX company
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Schering Corporation (Kenilworth, NJ) 2039-03-29 RX company
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Schering Corporation (Kenilworth, NJ) 2014-10-11 RX company
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Hoffman-La Roche Inc. (Nutley, NJ) Genentech, Inc. (South San Francisco, CA) 2020-08-26 RX company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Patent Text Search: US Patents for INTRON A

These patents were identified by searching patent claims

Supplementary Protection Certificates for INTRON A

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
SPC/GB03/038 United Kingdom   Start Trial SPC/GB03/038: 20070115
CA 2010 00005 Denmark   Start Trial PRODUCT NAME: CORIFOLLITROPIN ALFA
122017000100 Germany   Start Trial PRODUCT NAME: NUSINERSEN ODER SALZE DAVON (INTERNATIONALER, NICHT FIRMENEIGENER NAME); REGISTRATION NO/DATE: EU/1/17/1188 20170530
300905 Netherlands   Start Trial PRODUCT NAME: NUSINERSEN, DESGEWENST IN DE VORM VAN EEN ZOUT; REGISTRATION NO/DATE: EU/1/17/1188 20170601
SZ 20/1995 Austria   Start Trial PRODUCT NAME: OCTOCOG ALFA
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Johnson and Johnson
Harvard Business School
Baxter
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.